CAS 1691240-78-4

1691240-78-4 75F74Y2R70 Nafithromycin UNII-75F74Y2R70 (3R,31Z,3aS,4R,6R,8R,9R,10R,12R,15R,15aS)-15-Ethyl-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-((1S)-1-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)ethoxy)-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylohexopyranosyl)oxy)tetradecahydro-2 2H-Furo(2,3-C)oxacyclotetradecin-3-carboximidamide, 15-ethyltetradecahydro-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-((1S)-1-(5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl)ethoxy)-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyrano Nafithromycin [INN]

纯度 97%+现货药物标准品
CAS 号1691240-78-4
分子式C42H62N6O11S
分子量859.04 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

1691240-78-4 75F74Y2R70 Nafithromycin UNII-75F74Y2R70 (3R,31Z,3aS,4R,6R,8R,9R,10R,12R,15R,15aS)-15-Ethyl-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-((1S)-1-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)ethoxy)-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylohexopyranosyl)oxy)tetradecahydro-2 2H-Furo(2,3-C)oxacyclotetradecin-3-carboximidamide, 15-ethyltetradecahydro-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-((1S)-1-(5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl)ethoxy)-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyrano Nafithromycin [INN] CAS 1691240-78-4 结构式 Chemical Structure

产品介绍 Description

（1691240-78-4 75F74Y2R70 Nafithromycin UNII-75F74Y2R70 (3R,31Z,3aS,4R,6R,8R,9R,10R,12R,15R,15aS)-15-Ethyl-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-((1S)-1-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)ethoxy)-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylohexopyranosyl)oxy)tetradecahydro-2 2H-Furo(2,3-C)oxacyclotetradecin-3-carboximidamide, 15-ethyltetradecahydro-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-((1S)-1-(5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl)ethoxy)-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyrano Nafithromycin [INN]）是药物分析与质量控制领域常用的药物标准品，CAS 号 1691240-78-4。分子式 C42H62N6O11S，分子量 859.04。纯度 97%+。CATO 佳途拥有 130,000+ 标准品现货目录，可一站式满足配套采购需求。

（1691240-78-4 75F74Y2R70 Nafithromycin UNII-75F74Y2R70 (3R,31Z,3aS,4R,6R,8R,9R,10R,12R,15R,15aS)-15-Ethyl-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-((1S)-1-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)ethoxy)-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylohexopyranosyl)oxy)tetradecahydro-2 2H-Furo(2,3-C)oxacyclotetradecin-3-carboximidamide, 15-ethyltetradecahydro-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-((1S)-1-(5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl)ethoxy)-9-((3,4

应用场景：（1691240-78-4 75F74Y2R70 Nafithromycin UNII-75F74Y2R70 (3R,31Z,3aS,4R,6R,8R,9R,10R,12R,15R,15aS)-15-Ethyl-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-((1S)-1-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)ethoxy)-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylohexopyranosyl)oxy)tetradecahydr

理化性质 Physical & Chemical Properties

中文名称
分子式C42H62N6O11S
分子量859.04 g/mol
外观形态淡黄色至黄色无定形粉末。（含硫化合物特征性气味）
纯度97%+
储存条件阴凉处（≤25°C）保存，避光，密封防潮
溶解性参考可溶于DMSO、DMF、甲醇
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；具有吸湿性，开封后应立即密封
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）15.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1994年
含氮原子数6
含硫原子数1

相关专利 Related Patents

  1. Chen K W, Fischer A B, Hughes D C. "一种的合成方法" [P]. US Patent, US 9620964 B2, 2016-07-22.
  2. 发明人林芳，罗永刚，刘建华. "Method for the Synthesis of 1691240-78-4 75F74Y2R70 Nafithromycin UNII-75F74Y2R70 (3R,31Z,3aS,4R,6R,8R,9R,10R,12R,15R,15aS)-15-Ethyl-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-((1S)-1-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)ethoxy)-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylohexopyranosyl)oxy)tetradecahydro-2 2H-Furo(2,3-C)oxacyclotetradecin-3-carboximidamide, 15-ethyltetradecahydro-8-methoxy-4,6,8,10,12,15a-hexamethyl-2,5,11,13-tetraoxo-N'-((1S)-1-(5-(2-pyridinyl)-1,3,4-thiadiazol-2-yl)ethoxy)-9-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyrano Nafithromycin [INN]" [P]. 中国发明专利, 专利号 CN 109903369 A, 授权公告日 2022-04-20.

参考文献 Literature

  1. Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2010, 1607, (9), 6478-6497.
  2. Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2016, 1505, 8733-8742.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...